Systemic, primary cutaneous, and breast implant-associated ALK-negative anaplastic large-cell lymphomas present similar biologic features despite distinct clinical behavior

Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

Nathalie A. Johnson, Graham W. Slack, Kerry J. Savage et al. · Journal of Clinical Oncology · 2012 · 973 citations

Medicine, Cancer Biology, Oncology +13

ALK− anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

Kerry J. Savage, Nancy L. Harris, Julie M. Vose et al. · Blood · 2008 · 854 citations · Full text

Medicine, Oncology, Pathology +12

Primary and secondary cutaneous CD30+lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment

Marcel W. Bekkenk, Françoise A. M. J. Geelen, Pieter C. van Voorst Vader et al. · Blood · 2000 · 782 citations

Medicine, Dermatology, Pathology +16

Aberrant PD-L1 expression through 3′-UTR disruption in multiple cancers

Keisuke Kataoka, Yuichi Shiraishi, Yohei Takeda et al. · Nature · 2016 · 638 citations

Medicine, Molecular Genetics, Oncology +16

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Bjoern Chapuy, Margaretha G.M. Roemer, Chip Stewart et al. · Blood · 2015 · 599 citations · Full text

Medicine, Genetics, Molecular Genetics +16